Zydus’ biopharma arm acquires global proprietary rights for Progeria treatment
Sentynl, under Zydus Lifesciences, acquired global rights for Zokinvy, the first FDA-approved Progeria treatment. An acquisition milestone in expanding the rare disease medicines portfolio, focusing on supporting patients.
Be a part of verified social community platform. Qoneqt intends to bring authenticity in communication between communities and Individuals online with real faces.
Be a part of verified social community platform. Qoneqt intends to bring authenticity in communication between communities and Individuals online with real faces.